Table 2.
Multivariable analysis of time from symptom onset to hospital discharge in COVID-19 patients with moderate and severe infections.
| variables | Moderate patients | Severe patients | ||||
|---|---|---|---|---|---|---|
| Coefficient (SE) | t | P-value | Coefficient (SE) | t | P-value | |
| Gender (male = 1, female = 0) | −1.16 (0.54) | −2.13 | 0.0335 | −0.02 (0.92) | −0.02 | 0.9870 |
| EF (yes = 1, no = 0) | 1.83 (0.61) | 3.01 | 0.0028 | 7.83 (3.23) | 2.42 | 0.0164 |
| Neutrophil (109/L) | 0.50 (0.52) | 0.96 | 0.3391 | −0.00 (0.02) | −0.09 | 0.9309 |
| Lymphocyte (109/L) | −0.49 (0.54) | −0.91 | 0.3610 | −0.09 (0.33) | −0.27 | 0.7859 |
| Eosinophil (109/L) | 1.26 (0.53) | 2.4 | 0.0167 | −0.19 (0.21) | −0.9 | 0.3691 |
| CRP (mg/L) | 2.47 (0.58) | 4.26 | <0.0001 | −0.04 (0.02) | −1.69 | 0.0923 |
| PCT (ng/mL) | 0.86 (0.51) | 1.69 | 0.0919 | −0.06 (0.55) | −0.11 | 0.9140 |
| IL-6 (pg/mL) | 1.78 (0.59) | 3.00 | 0.0028 | 0.12 (0.06) | 2.07 | 0.0398 |
COVID-19, coronavirus disease; EF, early fever; PCT, procalcitonin; CRP, high-sensitivity C-reactive protein; IL-6, interleukin-6; SE, standard error. A generalized linear regression model was developed, and the p-values for the coefficients indicate whether these relationships are statistically significant.